R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 78.07
-0.28 (-0.36%)
At close: Feb 12, 2026
55.30% (1Y)
| Market Cap | 7.43B +71.7% |
| Revenue (ttm) | 789.45M +4.1% |
| Net Income | 151.37M +25.0% |
| EPS | 1.59 +26.1% |
| Shares Out | 95.14M |
| PE Ratio | 49.06 |
| Forward PE | 49.88 |
| Dividend | 0.16 (0.20%) |
| Ex-Dividend Date | Jul 8, 2025 |
| Volume | 1,699,547 |
| Average Volume | 3,022,072 |
| Open | 77.95 |
| Previous Close | 78.35 |
| Day's Range | 77.50 - 80.74 |
| 52-Week Range | 40.99 - 91.78 |
| Beta | 0.74 |
| RSI | 58.42 |
| Earnings Date | Mar 28, 2026 |